Cargando…
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
The telomeric amplicon at 8p12 is common in oestrogen receptor-positive (ER+) breast cancers. Array-CGH and expression analyses of 1172 primary breast tumours revealed that ZNF703 was the single gene within the minimal amplicon and was amplified predominantly in the Luminal B subtype. Amplification...
Autores principales: | Holland, Daniel G, Burleigh, Angela, Git, Anna, Goldgraben, Mae A, Perez-Mancera, Pedro A, Chin, Suet-Feung, Hurtado, Antonio, Bruna, Alejandra, Ali, H Raza, Greenwood, Wendy, Dunning, Mark J, Samarajiwa, Shamith, Menon, Suraj, Rueda, Oscar M, Lynch, Andy G, McKinney, Steven, Ellis, Ian O, Eaves, Connie J, Carroll, Jason S, Curtis, Christina, Aparicio, Samuel, Caldas, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395113/ https://www.ncbi.nlm.nih.gov/pubmed/21337521 http://dx.doi.org/10.1002/emmm.201100122 |
Ejemplares similares
-
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011) -
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer
por: Sircoulomb, Fabrice, et al.
Publicado: (2011) -
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors
por: Bazarov, Alexey V, et al.
Publicado: (2011) -
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013) -
Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling
por: Zhang, Xi, et al.
Publicado: (2013)